Announcing a new publication for Acta Materia Medica journal. Phosphodiesterase-4 (PDE4), a member of the phosphodiesterase ...

A mother-of-two claims to have found a "miracle" cure for her psoriasis almost three decades after first being diagnosed with ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Medicare coverage for psoriasis drugs depends on the type ... systemic oral drugs, biologic treatments, or injections. A formulary is a list of drugs that your plan covers. If your plan’s ...

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...

For years, Kate Scott struggled with psoriasis ... Doctors also suggested more aggressive treatments, including immunosuppressant injections that would require regular blood tests.